Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including ...

T. Schneider via Shutterstock.com. The US Food and Drug Administration (FDA) has delayed decisions on two regulatory ...

Regeneron Pharmaceuticals ( NASDAQ: REGN) announced that the U.S. FDA has extended the target action dates for two regulatory ...

Newsweek, in partnership with Statista, is proud to announce the sixth edition of America’s Best Physical Rehabilitation Centers, recognizing 320 leading inpatient facilities across the United States.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates to the fourth quarter of 2025 for two EYLEA HD® ...

VivaVision Biotech welcomes renowned ophthalmologist Quan Dong Nguyen to its scientific advisory board with hopes of boosting ...